Publications

Publications

Filter Results: (144) Arrow Down
Filter Results: (144) Arrow Down Arrow Up

Show Results For

Show Results For

← Page 3 of 144 Results →
Sort by

Are you looking for?

→Search All HBS Web
  • February 2022 (Revised August 2022)
  • Case

Defense Logistics Agency: Dynamic Vaccine Distribution at Scale

By: Hise Gibson, Gary P. Pisano, Pettis Kent and Michael Norris
Related
  • September 2020 (Revised July 2021)
  • Case

Moderna (A)

By: Marco Iansiti, Karim R. Lakhani, Hannah Mayer and Kerry Herman
In summer 2020, Stephane Bancel, CEO of biotech firm Moderna, faces several challenges as his company races to develop a vaccine for COVID-19. The case explores how a company builds a digital organization, and leverages artificial intelligence and other digital... View Details
Keywords: COVID-19; Vaccine; Digital Organizations; Organizational Structure; Operations; Management; Health Pandemics; Research and Development; Goals and Objectives
Related
  • August 2021
  • Teaching Note

Fair Park Covid-19 Mass Vaccination Site (A) and (B)

By: Willy Shih
Teaching Note for HBS Case Nos. 622-003 and 622-004. View Details
Keywords: Operations Improvement; Operations And Processes; Toyota Production System; Operations; Service Operations; Health Pandemics; Service Delivery; Problems and Challenges; Goals and Objectives; Measurement and Metrics; Health Industry; United States
Related
  • 10 Feb 2023
  • Research & Ideas

COVID-19 Lessons: Social Media Can Nudge More People to Get Vaccinated

Public health officials who took to social media to push people to get the COVID-19 vaccine may have wondered if they were screaming into a void. Over the course of the pandemic, health agencies around the world—ranging from the World... View Details
Keywords: by Scott Van Voorhis; Health; Technology
  • Article

Ein Booster für die Pharmabranche [A Booster for the Pharmaceutical Industry]

By: Ariel Dora Stern, Timo Minssen, W. Nicholson Price, II and Christoph Grimpe
mRNA technology has just helped to develop vaccines against COVID-19. Now, like Apple's iOS, it could provide the basis for new innovation platforms. View Details
Keywords: mRNA; COVID-19; Vaccines; Health Care and Treatment; Health Pandemics; Innovation and Invention; Health Industry
Related
  • Article

Vaccines Use Bizarre Stuff. We Need a Supply Chain Now.

By: Scott Duke Kominers and Alex Tabarrok
Related
  • January 2021 (Revised March 2021)
  • Case

Serum Institute of India (SII): Racing to Save Lives During a Pandemic

By: Rohit Deshpandé, Anjali Raina and Rachna Chawla
The CEO of Serum Institute of India (SII), a $12.8 billion Indian Family business is faced with a risky choice between principles and profit. SII is the largest manufacturer of vaccines in the world and Adar Poonawalla, the CEO and son of the founder has to decide how... View Details
Keywords: Business Ethics; Healthcare; COVID-19; Vaccines; Family Business; Ethics; Health Care and Treatment; Health Pandemics; Leadership; Corporate Accountability; Fairness; Growth and Development Strategy; Health Industry; India; South Asia
Related
  • May 2020 (Revised April 2024)
  • Case

Gavi and COVID-19: Pandemic of the Century

By: Tarun Khanna and Sid Misra
Gavi has helped immunize over 760 million children in the world's poorest countries over the past 20 years saving 13 million lives. How should Gavi respond to the need for a vaccine for the worldwide COVID-19 pandemic? View Details
Keywords: Vaccine; Pandemics; Healthcare; COVID-19; Health Pandemics; Health Care and Treatment; Emerging Markets; Crisis Management; Alliances
Related
  • March 13, 2020
  • Editorial

Scale the Price for a Coronavirus Vaccine by the Harm it Averts

By: Amitabh Chandra
Related
  • October 2024
  • Article

Greater Covid-19 Vaccine Uptake among enrollees Offered Health and Social Needs Case Management: Results from a Randomized Trial

By: Margae Knox, Elizabeth A. Hernandez, Daniel M. Brown, Jennifer Ahern, Mark D. Fleming, Crystal Guo and Amanda L. Brewster
The CommunityConnect case management program for Medicaid beneficiaries is run by Contra Costa Health, a county safety net health system in California. Case management infrastructure modestly improved Covid-19 vaccine uptake in a population of Medicaid beneficiaries... View Details
Keywords: Health Care and Treatment; Health Pandemics; Medical Specialties; Programs; Human Needs; Welfare; Health Industry; California
Related
  • May 2014 (Revised January 2015)
  • Case

Vaxess Technologies, Inc.

By: John A. Quelch and Margaret L. Rodriguez
In February 2014, Michael Schrader, chief executive of Vaxess Technologies, Inc., was assessing the startup health care company's 2014 marketing plan. On December 31st, 2013, Vaxess had obtained an exclusive license to a series of patents for a silk protein technology... View Details
Keywords: Vaccine; Cold Chain; Antigen; Temperature Controlled; Developing Markets; Immunization; Health Care and Treatment; Health Pandemics; Global Strategy; Supply Chain; Health; Health Industry; Medical Devices and Supplies Industry
Related
  • October 2021 (Revised January 2022)
  • Supplement

Michael Ku and Global Clinical Supply at Pfizer Inc.: Bringing Hope to Patients (C)

By: Linda A. Hill and Emily Tedards
This case is the third installment in a series about the 10-year cultural and digital transformation of Pfizer’s Global Clinical Supply organization. In 2011, Michael Ku became Pfizer’s Vice President of Global Clinical Supply (GCS) after the company had undergone... View Details
Keywords: Clinical Supply Chain; COVID-19; Vaccine; Agile; Innovation and Invention; Change Management; Organizational Culture; Transformation; Leadership; Corporate Strategy; Health Pandemics; Crisis Management; Mission and Purpose; Health Care and Treatment; Supply Chain Management; Digital Transformation
Related
  • February 2015 (Revised November 2015)
  • Case

Building an Integrated Biopharma Company: Crucell (A)

By: Richard G. Hamermesh, Marianne Van Der Steen and Susan S. Harmeling
By 2009, Crucell had become the largest biopharma company in the Netherlands and a symbol of national pride. The case traces the evolution of the company from a University spin-off into a fully-integrated company. Crucell's success, particularly in the vaccine space,... View Details
Keywords: Biotechnology; Biopharmacy Company; Licensing; Licensing Agreements In Biopharmacy; Human Cell-line Technology; Vaccine; Healthcare Innovation; Global Health; Partners and Partnerships; Entrepreneurship; Growth and Development Strategy; Biotechnology Industry; Pharmaceutical Industry; Netherlands
Related
  • Article

Health Equity, Schooling Hesitancy, and the Social Determinants of Learning

By: Meira Levinson, Alan C. Geller, Joseph G. Allen and John D. Macomber
At least 62 million K-12 students in North America—disproportionately low-income children of color— have been physically out of school for over a year due to the COVID-19 pandemic. These children are at risk of significant academic, social, mental, and physical harm... View Details
Keywords: COVID-19; Public Health; Air Quality; Social Determinants Of Health; Schooling Hesitancy; Vaccine Hesitancy; Racial Injustice; Inequity; Inequality; Health Pandemics; Education; Health Care and Treatment; Policy; Race; Equality and Inequality
Related
  • February 2023
  • Article

Maintaining Health Care Innovations After the Pandemic

By: Regina E. Herzlinger, Barak D. Richman and Kevin A. Schulman
The COVID-19 pandemic exposed the worst failings of the health care system, but it also stimulated a flurry of innovations that could lead to a much-improved delivery system. These were innovations that were born out of necessity: telemedicine access and use... View Details
Keywords: Health Care; Health Care Industry; Health Care Outcomes; Innovation; Innovation In Healthcare Delivery; COVID; COVID-19 Pandemic; Pandemics; Telemedicine; Telehealth; Ambulatory Care; Vaccines; Innovation and Invention; Change; Health Industry
Related
  • 2022
  • Editorial

It’s Time to Redouble and Refocus Our Efforts to Fight COVID, Not Retreat

By: Kathleen Bachynski, Brian C. Castrucci, Esther K. Choo, Ranu Dhillon, Jim Downs, Lakshmi Ganapathi, Gregg Gonsalves, Abraar Karan, Richard C. Keller, Scott Duke Kominers, Jonathan Levy, Martha Lincoln, Seth Prins, Julia Raifman and Anne Sosin
Keywords: COVID; COVID-19; COVID-19 Pandemic; Public Health; Public Health Measures; Vaccination; Health Policy; Health Pandemics; Government and Politics; United States
Related
  • February 2015 (Revised November 2015)
  • Supplement

Building an Integrated Biopharma Company: Crucell (B)

By: Richard G. Hamermesh, Marianne Van Der Steen and Susan Harmeling
The Crucell (B) case updates events at Crucell since 2009. In September, 2009, Johnson & Johnson acquired 18% of Crucell for $400 million. This investment was part of a business development deal. Subsequently, in 2012, Johnson & Johnson acquired Crucell for $2.8... View Details
Keywords: Biotechnology; Biopharmacy Company; Licensing Agreements In Biopharmacy; Licensing; Human Cell-line Technology; Vaccine; Healthcare Innovation; Global Health; Entrepreneurship; Health Care and Treatment; Acquisition; Innovation and Invention; Biotechnology Industry; Pharmaceutical Industry
Related
  • April 2022
  • Teaching Note

CVS Health: Prescription for Transformation

By: Rosabeth Moss Kanter and Catarina Martinez
In 2021, new CEO Karen Lynch (named the most powerful woman in business) considered the next transformation phase for CVS Health (a Fortune 5 corporate giant). The 2018 acquisition of Aetna insurance brought her to the company as part of its long evolution from a... View Details
Keywords: Health; COVID-19 Pandemic; Primary Care; Leadership; Change Management; Women Executives; Retail; Pharmacy; Pharmacy Benefit Manager; Clinical Trials; Vaccination; Acquisition; Innovation and Invention; Transformation; Retail Industry; Pharmaceutical Industry; Health Industry; United States
Related
  • 15 Dec 2021
  • Research & Ideas

The 10 Most Popular Articles of 2021

Many people began 2021 with optimism, hopeful that a COVID-19 vaccine would be widely available within months. Surely the pandemic would end soon, right? It was, perhaps, a naïve thought in a pandemic-weary world. Nevertheless, companies... View Details
Keywords: by Danielle Kost
  • March 2023
  • Case

Moderna

By: Marco Iansiti, Karim R. Lakhani, Hannah Mayer, Kerry Herman, Allison J. Wigen and Dave Habeeb
This multimedia case follows the story of Moderna and its entry into vaccine development in the wake of the COVID-19 pandemic. In summer 2020, Stephane Bancel, CEO of biotech firm Moderna, faces several challenges as his company races to develop a vaccine for COVID-19.... View Details
Keywords: Health Pandemics; Research and Development; Digital Transformation; Health Testing and Trials; Biotechnology Industry; Pharmaceutical Industry
Related

Are you looking for?

→Search All HBS Web